Get started
Bristol-Myers Squibb CompanyBristol-Myers Squibb CompanyBristol-Myers Squibb Company

Bristol-Myers Squibb Company

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

BMY chart


Full chart

Key facts today


Bristol Myers Squibb's long-term revenue growth has been reported at an annualized rate of 6.5% over the last five years, which falls below the benchmark for the healthcare sector.
Analyze the impactAnalyze the impact

BMY upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪77.06 B‬ CHF
Dividend yield (indicated)
5.22%
Price to earnings Ratio (TTM)
22.63
Basic EPS (TTM)
1.97 CHF
Net income (FY)
‪−8.13 B‬ CHF
Revenue (FY)
‪43.87 B‬ CHF
Shares float
‪2.03 B‬
Beta (1Y)
0.27

Employees


Employees (FY)
‪34.1 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪1.29 M‬ CHF
Net income / Employee (1Y)
‪−238.32 K‬ CHF

About Bristol-Myers Squibb Company


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Christopher S. Boerner
Website
bms.com
Headquarters
Princeton
Founded
1933
ISIN
US1101221083
FIGI
BBG006TLNGG0
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Check out other big names from the same industry as BMY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BMY news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

BMY highest yielding bonds


BMY5009251
Bristol-Myers Squibb Company 4.35% 15-NOV-2047
Yield to maturity
—
Maturity date
Nov 15, 2047
BMY4945645
Bristol-Myers Squibb Company 3.9% 20-FEB-2028
Yield to maturity
—
Maturity date
Feb 20, 2028
BMY4831826
Bristol-Myers Squibb Company 4.125% 15-JUN-2039
Yield to maturity
—
Maturity date
Jun 15, 2039
BMY.GB
Bristol-Myers Squibb Company 6.8% 15-NOV-2026
Yield to maturity
—
Maturity date
Nov 15, 2026
BMY4926518
Bristol-Myers Squibb Company 3.45% 15-NOV-2027
Yield to maturity
—
Maturity date
Nov 15, 2027
BMY5754772
Bristol-Myers Squibb Company FRN 20-FEB-2026
Yield to maturity
—
Maturity date
Feb 20, 2026
BMY5009253
Bristol-Myers Squibb Company 4.625% 15-MAY-2044
Yield to maturity
—
Maturity date
May 15, 2044
BMY5009250
Bristol-Myers Squibb Company 4.55% 20-FEB-2048
Yield to maturity
—
Maturity date
Feb 20, 2048
C
BMY3685700
Celgene Corporation 5.7% 15-OCT-2040
Yield to maturity
—
Maturity date
Oct 15, 2040
C
BMY4597874
Celgene Corporation 4.55% 20-FEB-2048
Yield to maturity
—
Maturity date
Feb 20, 2048
C
BMY4124214
Celgene Corporation 4.625% 15-MAY-2044
Yield to maturity
—
Maturity date
May 15, 2044

See all BMY bonds 

Sparks


Curated watchlists where BMY is featured.

See all sparks 

Frequently Asked Questions


The current price of BMY is 44.50 CHF — it hasn't changed in the past 24 hours. Watch Bristol-Myers Squibb Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Bristol-Myers Squibb Company stocks are traded under the ticker BMY.
We've gathered analysts' opinions on Bristol-Myers Squibb Company future price: according to them, BMY price has a max estimate of 54.86 CHF and a min estimate of 27.43 CHF. Watch BMY chart and read a more detailed Bristol-Myers Squibb Company stock forecast: see what analysts think of Bristol-Myers Squibb Company and suggest that you do with its stocks.
BMY reached its all-time high on Jul 25, 2016 with the price of 74.30 CHF, and its all-time low was 44.50 CHF and was reached on Jun 24, 2019. View more price dynamics on BMY chart.
See other stocks reaching their highest and lowest prices.
BMY stock is 0.00% volatile and has beta coefficient of 0.27. Track Bristol-Myers Squibb Company stock price on the chart and check out the list of the most volatile stocks — is Bristol-Myers Squibb Company there?
Today Bristol-Myers Squibb Company has the market capitalization of ‪77.06 B‬, it has decreased by −0.78% over the last week.
Yes, you can track Bristol-Myers Squibb Company financials in yearly and quarterly reports right on TradingView.
Bristol-Myers Squibb Company is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
BMY earnings for the last quarter are 1.16 CHF per share, whereas the estimation was 0.87 CHF resulting in a 33.79% surprise. The estimated earnings for the next quarter are 1.34 CHF per share. See more details about Bristol-Myers Squibb Company earnings.
Bristol-Myers Squibb Company revenue for the last quarter amounts to ‪9.73 B‬ CHF, despite the estimated figure of ‪9.08 B‬ CHF. In the next quarter, revenue is expected to reach ‪9.36 B‬ CHF.
BMY net income for the last quarter is ‪1.04 B‬ CHF, while the quarter before that showed ‪2.17 B‬ CHF of net income which accounts for −52.20% change. Track more Bristol-Myers Squibb Company financial stats to get the full picture.
Yes, BMY dividends are paid quarterly. The last dividend per share was 0.49 CHF. As of today, Dividend Yield (TTM)% is 5.17%. Tracking Bristol-Myers Squibb Company dividends might help you take more informed decisions.
As of Sep 13, 2025, the company has ‪34.1 K‬ employees. See our rating of the largest employees — is Bristol-Myers Squibb Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bristol-Myers Squibb Company EBITDA is ‪15.03 B‬ CHF, and current EBITDA margin is 39.98%. See more stats in Bristol-Myers Squibb Company financial statements.
Like other stocks, BMY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bristol-Myers Squibb Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bristol-Myers Squibb Company technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bristol-Myers Squibb Company stock shows the sell signal. See more of Bristol-Myers Squibb Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.